Brustbildgebung / Mammografie – Bildgebung und Vorgehen bei präinvasiven Läsionen der Mamma

S. Weigel; T. Decker; W. Heindel

doi:10.1055/s-0033-1346858

Senologie - Zeitschrift für Mammadiagnostik und -therapie, Inhaltsverzeichnis

Senologie - Zeitschrift für Mammadiagnostik und -therapie 2013; 10(3): 142-153
DOI: 10.1055/s-0033-1346858

Aktuell diskutiert

Georg Thieme Verlag KG Stuttgart · New York

Brustbildgebung / Mammografie – Bildgebung und Vorgehen bei präinvasiven Läsionen der Mamma

Autor*innen

S. Weigel
T. Decker
W. Heindel

Abstract

Volltext

Referenzen

Literatur
1 Reis-Filho JS, Lakhani SR. The diagnosis and management of pre-invasive breast disease: genetic alterations in pre-invasive lesions. Breast Cancer Res 2003; 5: 313-319
2 Buerger H, Otterbach F, Simon R et al. Comparative genomic hybridization of ductal carcinoma in situ of the breast-evidence of multiple genetic pathways. J Pathol 1999; 187: 396-402
3 Simpson PT, Reis-Filho JS, Gale T et al. Molecular evolution of breast cancer. J Pathol 2005; 205: 248-254
4 Ellis IO. Intraductal proliferative lesions of the breast: morphology, associated risk and molecular biology. Mod Pathol 2010; 23: S1-S7
5 Simpson PTP, Gale TB, Reis-Filho JSM et al. Columnar Cell Lesions of the Breast: The Missing Link in Breast Cancer Progression? A Morphological and Molecular Analysis. American Journal of Surgical Pathology 2005; 29: 734-746
6 Buerger H, Schmidt H, Beckmann A et al. Genetic characterisation of invasive breast cancer: a comparison of CGH and PCR based multiplex microsatellite analysis. J Clin Pathol 2001; 54: 836-840
7 Reis-Filho JS, Simpson PT, Gale T et al. The molecular genetics of breast cancer: the contribution of comparative genomic hybridization. Pathol Res Pract 2005; 201: 713-725
8 American College of Radiology (ACR). Illustrated breast imaging reporting and data system (BI-RADS). Reston, VA: American College of Radiology; 2003
9 Page DL, Dupont WD, Rogers LW et al. Continued local recurrence of carcinoma 15–25 years after a diagnosis of Low-Grade-ductal carcinoma in situ of the breast treated only by biopsy. Cancer 1995; 76: 1197-1200
10 Wells CA, Amendoeira I, Apostolikas N et al. Quality assurance guidelines for pathology – Cytological and histological non-operative diagnosis. In: Perry NM, Broeders M, de Wolf C, et al., eds European guidelines for quality assurance in breast cancer screening and diagnosis. Luxembourg: Office for Official Publication of the European Communities; 2006
11 Weigel S, Girnus R, Czwoydzinski J et al. Digital mammography screening: average glandular dose and first performance parameters. Fortschr Röntgenstr 2007; 179: 892-895
12 Hartmann LC, Sellers TA, Frost MH et al. Benign breast disease and the risk of breast cancer. N Engl J Med 2005; 353: 229-237
13 Degnim AC, Visscher DW, Berman HK et al. Stratification of Breast Cancer Risk in Women With Atypia: A Mayo Cohort Study. J Clin Oncol 2007; 25: 2671-2677
14 Collins LC, Baer HJ, Tamimi RM et al. Magnitude and laterality of breast cancer risk according to histologic type of atypical hyperplasia: results from the Nurses“ Health Study. Cancer 2007; 109: 180-187
15 Thomssen C, Harbeck N. Update 2010 of the German AGO Recommendations for the Diagnosis and Treatment of Early and Metastatic Breast Cancer – Chapter B: Prevention, Early Detection, Lifestyle, Premalignant Lesions, DCIS, Recurrent and Metastatic Breast Cancer. Breast Care (Basel) 2010; 5: 345-351
16 Lieske B, Ravichandran D, Alvi A et al. Screen-detected breast lesions with an indeterminate (B3) core needle biopsy should be excised. Eur J Surg Oncol 2008; 34: 1293-1298
17 El-Sayed ME, Rakha EA, Reed J et al. Predictive value of needle core biopsy diagnoses of lesions of uncertain malignant potential (B3) in abnormalities detected by mammographic screening. Histopathology 2008; 53: 650-657
18 Weigel S, Decker T, Korsching E et al. Minimal Invasive Biopsy Results of „Uncertain Malignant Potential“ in Digital Mammography Screening: High Prevalence but also High Predictive Value for Malignancy. Fortschr Röntgenstr 2011; 183: 743-748
19 Flegg K, Flaherty J, Bicknell A et al. Surgical outcomes of borderline breast lesions detected by needle biopsy in a breast screening program. World Journal of Surgical Oncology 2010; 8: 78
20 Bijker N, Rutgers EJ, Peterse J L et al. Variations in diagnostic and therapeutic procedures in a multicentre, randomized clinical trial (EORTC 10 853) investigating breast-conserving treatment for DCIS. Eur J Surg Oncol 2001; 27: 135-140
21 de Mascarel I, Macgrogan G, Mathoulin-Pelissier S et al. Epithelial atypia in biopsies performed for microcalcifications. practical considerations about 2833 serially sectioned surgical biopsies with a long follow-up. Virchows Arch 2007; 451: 1-10
22 Eusebi V, Feudale E, Foschini MP et al. Long-term follow-up of in situ carcinoma of the breast. Semin Diagn Pathol 1994; 11: 223-235
23 Badve S, Dabbs DJ, Schnitt SJ et al. Basal-like and triple-negative breast cancers: a critical review with an emphasis on the implications for pathologists and oncologists. Mod Pathol 2011; 24: 157-167
24 Abdel-Fatah TMA, Powe DG, Hodi Z et al. Morphologic and Molecular Evolutionary Pathways of Low Nuclear Grade Invasive Breast Cancers and Their Putative Precursor Lesions: Further Evidence to Support the Concept of Low Nuclear Grade Breast Neoplasia Family. The American Journal of Surgical Pathology 2008; 32: 513-523
25 Kunju LP, Kleer CG. Significance of flat epithelial atypia on mammotome core needle biopsy: should it be excised?. Human Pathology 2007; 38: 35-41
26 Weigel S, Decker T, Korsching E et al. Calcifications in Digital Mammographic Screening: Improvement of Early Detection of Invasive Breast Cancers?. Radiology 2010; 255: 738-745
27 Foote FW, Steward FW. Lobular carcinoma in situ. American Journal of Pathology 1941; 17: 491-496
28 Haagensen CD, Lane N, Lattes R et al. Lobular neoplasia (so-called lobular carcinoma in situ) of the breast. Cancer 1978; 42: 737-769
29 Tavassoli FA, Devilee P. Pathology and Genetics of Tumours of the Breast and Female Genital Organs. Lyon: IARC-Press; Classification of Tumours. World Health Organisation 2003
30 Lakhani SR, Audretsch W, Cleton-Jensen AM et al. The management of lobular carcinoma in situ (LCIS). Is LCIS the same as ductal carcinoma in situ (DCIS)?. European Journal of Cancer 2006; 42: 2205-2211
31 Bratthauer GL, Tavassoli FA. Lobular intraepithelial neoplasia: previously unexplored aspects assessed in 775 cases and their clinical implications. Virchows Arch 2002; 440: 134-138
32 Hanby AM, Hughes TA. In situ and invasive lobular neoplasia of the breast. Histopathology 2008; 52: 58-66
33 Georgian-Smith D, Lawton TJ. Calcifications of lobular carcinoma in situ of the breast: radiologic-pathologic correlation. AJR Am J Roentgenol 2001; 176: 1255-1259
34 Page DL, Kidd TE, Dupont WD et al. Lobular neoplasia of the breast: higher risk for subsequent invasive cancer predicted by more extensive disease. Hum Pathol 1991; 22: 1232-1239
35 Akashi-Tanaka S, Fukutomi T, Nanasawa T et al. Treatment of noninvasive carcinoma: fifteen-year results at the National Cancer Center Hospital in Tokyo. Breast Cancer 2000; 7: 341-344
36 Li CI, Daling JR, Malone KE. Age-specific incidence rates of in situ breast carcinomas by histologic type, 1980 to 2001. Cancer Epidemiol Biomarkers Prev 2005; 14: 1008-1011
37 Frykberg ER. Lobular Carcinoma In Situ of the Breast. Breast J 1999; 5: 296-303
38 Ottesen GL, Graversen HP, Blichert-Toft M et al. Lobular carcinoma in situ of the female breast. Short-term results of a prospective nationwide study. The Danish Breast Cancer Cooperative Group. Am J Surg Pathol 1993; 17: 14-21
39 Ottesen GL, Graversen HP, Blichert-Toft M et al. Carcinoma in situ of the female breast. 10 year follow-up results of a prospective nationwide study. Breast Cancer Res Treat 2000; 62: 197-210
40 Goldstein NS, Kestin LL, Vicini FA. Clinicopathologic implications of E-cadherin reactivity in patients with lobular carcinoma in situ of the breast. Cancer 2001; 92: 738-747
41 Page DL, Schuyler PA, Dupont WD et al. Atypical lobular hyperplasia as a unilateral predictor of breast cancer risk: a retrospective cohort study. Lancet 2003; 361: 125-129
42 Hussain M, Cunnick GH. Management of lobular carcinoma in-situ and atypical lobular hyperplasia of the breast – a review. European Journal of Surgical Oncology 2011; 37: 279-289
43 Ciocca RM, Li T, Freedman GM et al. Presence of lobular carcinoma in situ does not increase local recurrence in patients treated with breast-conserving therapy. Ann Surg Oncol 2008; 15: 2263-2271
44 Deutsche Gesellschaft für Senologie, Deutsche Krebsgesellschaft. Stufe-3-Leitlinie Brustkrebs-Früherkennung in Deutschland. München: Zuckschwerdt; 2008